By ANDREW POLLACK
Lower-than-expected sales of the most important drugs manufactured by Sanofi and Gilead Sciences affected the share price of the drug companies.
Published: October 29, 2014 at 12:00AM
from NYT Business Day http://ift.tt/1wKPrTM
via IFTTT
from WordPress http://ift.tt/1oXQugG
No comments:
Post a Comment